IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA advisory panel votes against vaccine booster for most Americans


An FDA advisory committee overwhelmingly rejected a third dose of Pfizer’s vaccine for most adults, but in an unexpected second vote authorized its use for those 65 and older and people at high risk of contracting severe Covid-19.